SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000895345-19-000100
Filing Date
2019-02-14
Accepted
2019-02-14 08:09:31
Documents
2
Group Members
ALLEGHENY NEW MOUNTAIN PARTNERS, L.P.NEW MOUNTAIN AFFILIATED INVESTORS II, L.P.NEW MOUNTAIN CAPITAL GROUP, L.P.NEW MOUNTAIN CAPITAL, L.L.C.NEW MOUNTAIN PARTNERS II (AIV-A), L.P.NEW MOUNTAIN PARTNERS II (AIV-B), L.P.NM HOLDINGS GP, L.L.C.STEVEN B. KLINSKY

Document Format Files

Seq Description Document Type Size
1 ag13ga3-bellerophon_newmtn.htm SC 13G/A 325640
2 ag13ga3-ex99_1.htm EX-99.1 39509
  Complete submission text file 0000895345-19-000100.txt   367158
Mailing Address 787 SEVENTH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE 49TH FLOOR NEW YORK NY 10019 212-720-0300
New Mountain Investments II, LLC (Filed by) CIK: 0001415950 (see all company filings)

IRS No.: 900173275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88741 | Film No.: 19600903
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1